2RW Stock Overview
ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 5/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
ReWalk Robotics Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$4.00 |
| 52 Week High | US$8.05 |
| 52 Week Low | US$3.39 |
| Beta | 2.07 |
| 1 Month Change | 0% |
| 3 Month Change | -28.57% |
| 1 Year Change | 2.41% |
| 3 Year Change | -65.37% |
| 5 Year Change | -81.18% |
| Change since IPO | -99.89% |
Recent News & Updates
Recent updates
Shareholder Returns
| 2RW | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 0% | -0.6% | 1.8% |
| 1Y | 2.4% | -9.5% | 2.2% |
Return vs Industry: 2RW exceeded the German Medical Equipment industry which returned -9.5% over the past year.
Return vs Market: 2RW matched the German Market which returned 2.2% over the past year.
Price Volatility
| 2RW volatility | |
|---|---|
| 2RW Average Weekly Movement | 15.9% |
| Medical Equipment Industry Average Movement | 4.6% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.1% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 2RW's share price has been volatile over the past 3 months.
Volatility Over Time: 2RW's weekly volatility (16%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 108 | Larry Jasinski | golifeward.com |
ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke. The company markets and sells its products directly to institutions and individuals, as well as through third-party distributors.
ReWalk Robotics Ltd. Fundamentals Summary
| 2RW fundamental statistics | |
|---|---|
| Market cap | €38.82m |
| Earnings (TTM) | -€20.68m |
| Revenue (TTM) | €12.94m |
3.0x
P/S Ratio-1.9x
P/E RatioIs 2RW overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2RW income statement (TTM) | |
|---|---|
| Revenue | US$13.85m |
| Cost of Revenue | US$9.40m |
| Gross Profit | US$4.45m |
| Other Expenses | US$26.59m |
| Earnings | -US$22.13m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -2.60 |
| Gross Margin | 32.14% |
| Net Profit Margin | -159.76% |
| Debt/Equity Ratio | 0% |
How did 2RW perform over the long term?
See historical performance and comparison